Law Offices of J. Robert Davis, LLP

Gadolinium Lawsuits Rise As Link To NSF Skin Disease Uncovered

FREE CASE REVIEW

Gadolinium is a heavy metal used in MRI scans which can cause a serious skin disease called Nephrogenic Systemic Fibrosis, often called NSF. People who develop NSF after an MRI scan should consult an attorney quickly.

If you had an MRI and now have skin problems then contact our attorneys now at 800-529-5072 or use the form on this page.

Symptoms of NSF caused by gadolinium:

• Tightening of the skin
• Swelling of the skin
• Thickening of the skin
• Dark skin patches
• Red skin patches
• Reduced flexibility or stiffness in arms, hands, legs or feet

"The requested warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF). In addition, it would state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing NSF if they are experiencing kidney insufficiency of any severity." Source: www.fda.gov/bbs/topics/NEWS/2007/NEW01638.html

Kidney disease is often associated with NSF from gadolinium. If you suspect any problems related to an MRI scan you had then take no chances. A free case review by attorneys at the Law Offices of J. Robert Davis LLP will quickly determine if you have a valid case and if you might receive financial compensation for your injuries.

MRI Agent Lawsuits - NSF Occurs in Patients With Kidney Problems

Published May 29, 2007 Patients suffering from kidney disease are at risk of developing NSF (Nephrogenic Systemic Fibrosis) after exposure to a substance given during routine MRI (Magnetic Resonance Imaging) scans.

During an MRI scan patients are given a substance known as a Contrast Agent which improves the visibility of the scanned images created by the MRI. One common agent containing gadolinium has been shown to cause NSF in patients with existing kidney problems. These MRI contrast agents are sometimes called gadolinium-containing agents or gadolinium-based agents.

The FDA first identified gadolinium agents as a risk in June of 2006. On May 23rd of 2007 the FDA requested that all box labels for gadolinium agents warn of “risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF).”

Patients will not usually be aware of exactly what type of agent was used during an MRI. If you have received an MRI and have NSF then contact The Law Offices of Robert Davis for a free legal case review. We can help determine a relation and ensure you receive professional legal representation if necessary.

---